Skip to main content
SpringerLink
Log in

Comorbidities and Their Management: Potential Impact on Breast Cancer Outcomes

  • Chapter
Improving Outcomes for Breast Cancer Survivors

Part of the book series: Advances in Experimental Medicine and Biology ((BCRF,volume 862))

Abstract

Pre-existing comorbidities negatively impacts overall breast cancer prognosis, increasing both breast cancer specific deaths as well as death from competing causes. Improvements in breast cancer survival in recent decades, however, have primarily been experienced among cancer patients without comorbidities, and less so among those with moderate or severe comorbidities. As guidelines for the treatment of breast cancer are mostly based on studies excluding patients with moderate and severe comorbidities with under-representation of older women with comorbid conditions, information regarding treatment effectiveness in breast cancer patients with comorbidities is currently lacking. This chapter describes the impact of comorbidities on breast cancer treatment and outcomes, previous research approaches taken, and specific populations that may be most susceptible to the effects of comorbidities on breast cancer outcomes. Future research directions are suggested that may help to improve understanding of comorbidity-related factors that underlie disparities in breast cancer outcomes, and to examine the potential role of effective management of comorbidities among breast cancer patients as a strategy to help close gaps in disease prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ahern TP, Pedersen L, Tarp M et al (2011) Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst 103(19):1461–1468

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Aizer AA, Wilhite TJ, Chen MH et al (2014) Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer 120(10):1532–1539

    PubMed  Google Scholar 

  • Albain KS, Unger JM, Crowley JJ et al (2009) Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst 101(14):984–992

    Article  PubMed Central  PubMed  Google Scholar 

  • Ballard-Barbash R, Potosky AL, Harlan LC et al (1996) Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 88(11):716–726

    Article  CAS  PubMed  Google Scholar 

  • Barron TI, Connolly RM, Sharp L et al (2011) Beta blockers and breast cancer mortality: a population- based study. J Clin Oncol 29(19):2635–2644

    Article  CAS  PubMed  Google Scholar 

  • Berglund A, Wigertz A, Adolfsson J et al (2012) Impact of comorbidity on management and mortality in women diagnosed with breast cancer. Breast Cancer Res Treat 135(1):281–289

    Article  PubMed  Google Scholar 

  • Berrino F, Villarini A, Traina A et al (2014) Metabolic syndrome and breast cancer prognosis. Breast Cancer Res Treat 147(1):159–165

    Article  PubMed  Google Scholar 

  • Blair CK, Sweeney C, Anderson KE et al (2007) NSAID use and survival after breast cancer diagnosis in post-menopausal women. Breast Cancer Res Treat 101(2):191–197

    Article  CAS  PubMed  Google Scholar 

  • Bo S, Benso A, Durazzo M et al (2012) Does use of metformin protect against cancer in Type 2 diabetes mellitus? J Endocrinol Invest 35(2):231–235

    Article  CAS  PubMed  Google Scholar 

  • Bosworth HB, Powers B, Grubber JM et al (2008) Racial differences in blood pressure control: potential explanatory factors. J Gen Intern Med 23(5):692–698

    Article  PubMed Central  PubMed  Google Scholar 

  • Bouchardy C, Rapiti E, Blagojevic S et al (2007) Older female cancer patients: importance, causes, and consequences of undertreatment. J Clin Oncol 25(14):1858–1869

    Article  PubMed  Google Scholar 

  • Braithwaite D, Tammemagi CM, Moore DH et al (2009) Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer 124(5):1213–1219

    Article  CAS  PubMed  Google Scholar 

  • Braithwaite D, Moore DH, Satariano WA et al (2012) Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev 21(7):1115–1125

    Article  PubMed Central  PubMed  Google Scholar 

  • Bush D, Smith B, Younger J et al (2011) The non-breast-cancer death rate among breast cancer patients. Breast Cancer Res Treat 127(1):243–249

    Article  PubMed  Google Scholar 

  • Calip GS, Boudreau DM, Loggers ET (2013) Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment. Breast Cancer Res Treat 138(1):225–233

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Calip GS, Hubbard RA, Stergachis A et al (2014) Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment. Pharmacoepidemiol Drug Saf. doi:10.1002/pds.3660

    PubMed  Google Scholar 

  • Carlsen K, Hoybye MT, Dalton SO et al (2008) Social inequality and incidence of and survival from breast cancer in a population-based study in Denmark, 1994-2003. Eur J Cancer 44(14):1996–2002

    Article  PubMed  Google Scholar 

  • Center for Disease Control, HIV surveillance report, 2010. http://www.cdc.gov/hiv/topics/surveillance/resources/reports. Accessed 11 Oct 2014

  • Centers for Medicare and Medicaid Services, Chronic Condition Warehouse. https://www.ccwdata.org/web/guest/home. Accessed 11 Oct 2014

  • Chao C, Page JH, Yang SJ et al (2014) History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in cancer patients not receiving G-CSF prophylaxis. Ann Oncol 25(9):1821–1829

    Article  CAS  PubMed  Google Scholar 

  • Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383

    Article  CAS  PubMed  Google Scholar 

  • Chia VM, Page JH, Rodriguez R et al (2013) Chronic comorbid conditions associated with risk of febrile neutropenia in breast cancer patients treated with chemotherapy. Breast Cancer Res Treat 138(2):621–631

    Article  CAS  PubMed  Google Scholar 

  • Cho H, Mariotto AB, Mann BS et al (2013) Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence. Am J Epidemiol 178(3):339–349

    Article  PubMed Central  PubMed  Google Scholar 

  • Cronin-Fenton DP, Norgaard M, Jacobsen J et al (2007) Comorbidity and survival of Danish breast cancer patients from 1995 to 2005. Br J Cancer 96(9):1462–1468

    CAS  PubMed Central  PubMed  Google Scholar 

  • Dalton SO, Ross L, During M et al (2007) Influence of socioeconomic factors on survival after breast cancer–a nationwide cohort study of women diagnosed with breast cancer in Denmark 1983–1999. Int J Cancer 121(11):2524–2531

    Article  CAS  PubMed  Google Scholar 

  • Dialla PO, Dabakuyo TS, Marilier S et al (2012) Population-based study of breast cancer in older women: prognostic factors of relative survival and predictors of treatment. BMC Cancer. doi:10.1186/1471-2407-12-472

    PubMed Central  PubMed  Google Scholar 

  • Du XL, Fang S, Meyer TE (2008) Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer. Am J Clin Oncol 31(2):125–132

    Article  PubMed  Google Scholar 

  • Earle CC, Burstein HJ, Winer EP et al (2003) Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol 21(8):1447–1451

    Article  PubMed  Google Scholar 

  • Edwards BK, Noone AM, Mariotto AB et al (2013) Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 120(9):1290–1314

    Article  PubMed Central  PubMed  Google Scholar 

  • Eley JW, Hill HA, Chen VW et al (1994) Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 272(12):947–954

    Article  CAS  PubMed  Google Scholar 

  • Field TS, Bosco JL, Prout MN et al (2011) Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer. J Am Coll Surg 213(6):757–765

    Article  PubMed Central  PubMed  Google Scholar 

  • Fisher KJ, Lee JH, Ferrante JM et al (2013) The effects of primary care on breast cancer mortality and incidence among Medicare beneficiaries. Cancer 119(16):2964–2972

    Article  PubMed  Google Scholar 

  • Fleming ST, Sabatino SA, Kimmick G et al (2011) Developing a claim-based version of the ACE-27 comorbidity index: a comparison with medical record review. Med Care 49(8):752–760

    Article  PubMed  Google Scholar 

  • Garg P, Rana F, Gupta R et al (2009) Predictors of toxicity and toxicity profile of adjuvant chemotherapy in elderly breast cancer patients. Breast J 15(4):404–408

    Article  CAS  PubMed  Google Scholar 

  • Gold HT, Makarem N, Nicholson JM et al (2014) Treatment and outcomes in diabetic breast cancer patients. Breast Cancer Res Treat 143(3):551–570

    Article  CAS  PubMed  Google Scholar 

  • Goodwin PJ, Stambolic V, Lemieux J et al (2011) Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents. Breast Cancer Res Treat 126(1):215–220

    Article  CAS  PubMed  Google Scholar 

  • Goodwin PJ, Ennis M, Pritchard KI et al (2012) Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. J Clin Oncol 30(2):164–171

    Article  PubMed  Google Scholar 

  • Griffiths RI, Gleeson ML, Valderas JM et al (2014) Impact of undetected comorbidity on treatment and outcomes of breast cancer. Int J Breast Cancer. doi:10.1155/2014/970780

    PubMed Central  PubMed  Google Scholar 

  • Guh DP, Zhang W, Bansback N et al (2009) The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. doi:10.1186/1471-2458-9-88

    PubMed Central  PubMed  Google Scholar 

  • Hadji P, Ziller V, Kyvernitakis J et al (2013) Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis. Breast Cancer Res Treat 138(1):185–191

    Article  CAS  PubMed  Google Scholar 

  • Hair BY, Hayes S, Tse CK et al (2014) Racial differences in physical activity among breast cancer survivors: implications for breast cancer care. Cancer 120(14):2174–2182

    Article  PubMed  Google Scholar 

  • Hanchate AD, Clough-Gorr KM, Ash AS et al (2010) Longitudinal patterns in survival, comorbidity, healthcare utilization and quality of care among older women following breast cancer diagnosis. J Gen Intern Med 25(10):1045–1050

    Article  PubMed Central  PubMed  Google Scholar 

  • Harlan LC, Klabunde CN, Ambs AH et al (2009) Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer. J Cancer Surviv 3(2):89–98

    Article  PubMed Central  PubMed  Google Scholar 

  • Harris EE, Hwang WT, Urtishak SL et al (2008) The impact of comorbidities on outcomes for elderly women treated with breast-conservation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys 70(5):1453–1459

    Article  PubMed  Google Scholar 

  • Helyer LK, Varnic M, Le LW et al (2010) Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J 16(1):48–54

    Article  PubMed  Google Scholar 

  • Hershman DL, Kushi LH, Shao T et al (2010) Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 28(27):4120–4128

    Article  PubMed Central  PubMed  Google Scholar 

  • Hewitt M, Greenfield S, Stovall E (2005) From cancer patient to cancer survivor: lost in transition. National Academies Press, Washington, DC

    Google Scholar 

  • Holmes MD, Chen WY (2012) Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality. Breast Cancer Res 14(2):216

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hosmer W, Malin J, Wong M (2011) Development and validation of a prediction model for the risk of developing febrile neutropenia in the first cycle of chemotherapy among elderly patients with breast, lung, colorectal, and prostate cancer. Support Care Cancer 19(3):333–341

    Article  PubMed Central  PubMed  Google Scholar 

  • Hou G, Zhang S, Zhang X et al (2013) Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes. Breast Cancer Res Treat 137(3):807–816

    Article  CAS  PubMed  Google Scholar 

  • Houterman S, Janssen-Heijnen ML, Verheij CD et al (2004) Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer 90(12):2332–2337

    CAS  PubMed Central  PubMed  Google Scholar 

  • Hutchins LF, Unger JM, Crowley JJ et al (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341(27):2061–2067

    Article  CAS  PubMed  Google Scholar 

  • Izano M, Satariano WA, Tammemagi MC et al (2014) Long-term outcomes among African-American and white women with breast cancer: what is the impact of comorbidity? J Geriatr Oncol 5(3):266–275

    Article  PubMed  Google Scholar 

  • Jagsi R, Abrahamse P, Morrow M et al (2009) Postmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process. Cancer 115(6):1185–1193

    Article  PubMed Central  PubMed  Google Scholar 

  • Jagsi R, Abrahamse P, Morrow M et al (2010) Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer. J Clin Oncol 28(14):2396–2403

    Article  PubMed Central  PubMed  Google Scholar 

  • Janssen-Heijnen ML, Houterman S, Lemmens VE et al (2005) Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 55(3):231–240

    Article  PubMed  Google Scholar 

  • Jordan JH, Thwin SS, Lash TL et al (2014) Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study. Breast Cancer Res Treat 146(2):401–409

    Article  PubMed  Google Scholar 

  • Jung SY, Rosenzweig M, Linkov F et al (2012) Comorbidity as a mediator of survival disparity between younger and older women diagnosed with metastatic breast cancer. Hypertension 59(2):205–211

    Article  CAS  PubMed  Google Scholar 

  • Kallogjeri D, Gaynor SM, Piccirillo ML et al (2014) Comparison of comorbidity collection methods. J Am Coll Surg 219(2):245–255

    Article  PubMed  Google Scholar 

  • Kimmick G, Fleming ST, Sabatino SA et al (2014) Comorbidity burden and guideline-concordant care for breast cancer. J Am Geriatr Soc 62(3):482–488

    Article  PubMed  Google Scholar 

  • Klabunde CN, Potosky AL, Legler JM et al (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258–1267

    Article  CAS  PubMed  Google Scholar 

  • Klabunde CN, Legler JM, Warren JL et al (2007) A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 17(8):584–590

    Article  PubMed  Google Scholar 

  • Klepin HD, Pitcher BN, Ballman KV et al (2014) Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (Alliance). J Oncol Pract 10(5):e285–e292

    Article  PubMed  Google Scholar 

  • Kwan ML, Habel LA, Slattery ML et al (2007) NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control 18(6):613–620

    Article  PubMed Central  PubMed  Google Scholar 

  • Kwan ML, Habel LA, Flick ED et al (2008) Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat 109(3):573–579

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kyanko KA, Franklin RH, Angell SY (2013) Adherence to chronic disease medications among New York City Medicaid participants. J Urban Health 90(2):323–328

    Article  PubMed Central  PubMed  Google Scholar 

  • Land LH, Dalton SO, Jensen MB et al (2012a) Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990–2008. Breast Cancer ResTreat 131(3):1013–1020

    Article  PubMed  Google Scholar 

  • Land LH, Dalton SO, Jorgensen TL et al (2012b) Comorbidity and survival after early breast cancer. A review. Crit Rev Oncol Hematol 81(2):196–205

    Article  PubMed  Google Scholar 

  • Land LH, Dalton SO, Jensen MB et al (2012c) Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer. Br J Cancer 107(11):1901–1907

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lash TL, Silliman RA, Guadagnoli E et al (2000) The effect of less than definitive care on breast carcinoma recurrence and mortality. Cancer 89(8):1739–1747

    Article  CAS  PubMed  Google Scholar 

  • Lee JJ, Swain SM (2006) Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 24(10):1633–1642

    Article  CAS  PubMed  Google Scholar 

  • Lee L, Cheung WY, Atkinson E et al (2011) Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review. J Clin Oncol 29(1):106–117

    Article  PubMed  Google Scholar 

  • Lotrionte M, Biondi-Zoccai G, Abbate A et al (2013) Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity. Am J Cardiol 112(12):1980–1984

    Article  CAS  PubMed  Google Scholar 

  • Louwman WJ, Janssen-Heijnen ML, Houterman S et al (2005) Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer 41(5):779–785

    Article  CAS  PubMed  Google Scholar 

  • Maskarinec G, Pagano IS, Yamashiro G et al (2003) Influences of ethnicity, treatment, and comorbidity on breast cancer survival in Hawaii. J Clin Epidemiol 56(7):678–685

    Article  PubMed  Google Scholar 

  • Mc Menamin UC, Murray LJ, Cantwell MM et al (2012) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review. Cancer Causes Control 23(2):221–230

    Article  PubMed  Google Scholar 

  • McPherson CP, Swenson KK, Lee MW (2002) The effects of mammographic detection and comorbidity on the survival of older women with breast cancer. J Am Geriatr Soc 50(6):1061–1068

    Article  PubMed  Google Scholar 

  • Nagel G, Wedding U, Rohrig B et al (2004) The impact of comorbidity on the survival of postmenopausal women with breast cancer. J Cancer Res Clin Oncol 130(11):664–670

    Article  CAS  PubMed  Google Scholar 

  • Nickels S, Vrieling A, Seibold P et al (2013) Mortality and recurrence risk in relation to the use of lipid-lowering drugs in a prospective breast cancer patient cohort. PLoS One 8(9):e75088

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Oeffinger KC, McCabe MS (2006) Models for delivering survivorship care. J Clin Oncol 24(32):5117–5124

    Article  PubMed  Google Scholar 

  • Ording AG, Cronin-Fenton DP, Jacobsen JB et al (2013) Comorbidity and survival of Danish breast cancer patients from 2000-2011: a population-based cohort study. Clin Epidemiol 5(Suppl 1):39–46

    Article  PubMed Central  PubMed  Google Scholar 

  • Patnaik JL, Byers T, Diguiseppi C et al (2011a) The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 103(14):1101–1111

    Article  PubMed Central  PubMed  Google Scholar 

  • Patnaik JL, Byers T, DiGuiseppi C et al (2011b) Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res 13(3):R64

    Article  PubMed Central  PubMed  Google Scholar 

  • Peairs KS, Barone BB, Snyder CF et al (2011) Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol 29(1):40–46

    Article  PubMed Central  PubMed  Google Scholar 

  • Perez EA, Suman VJ, Davidson NE et al (2008) Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol 26(8):1231–1238

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Piccirillo JF, Vlahiotis A, Barrett LB et al (2008) The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol 67(2):124–132

    Article  PubMed Central  PubMed  Google Scholar 

  • Polednak AP (2004) Racial differences in mortality from obesity-related chronic diseases in US women diagnosed with breast cancer. Ethn Dis 14(4):463–468

    PubMed  Google Scholar 

  • Riley GF (2009) Administrative and claims records as sources of health care cost data. Med Care 47(7 Suppl 1):S51–S55

    Article  PubMed  Google Scholar 

  • Ring A (2010) The influences of age and co-morbidities on treatment decisions for patients with HER2-positive early breast cancer. Crit Rev Oncol Hematol 76(2):127–132

    Article  PubMed  Google Scholar 

  • Ring A, Sestak I, Baum M et al (2011) Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen alone or in combination trial. J Clin Oncol 29(32):4266–4272

    Article  CAS  PubMed  Google Scholar 

  • Sabatino SA, Thompson TD, Wu XC et al (2014) The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer. Breast Cancer Res Treat 146(1):199–209

    Article  CAS  PubMed  Google Scholar 

  • Sarfati D, Gurney J, Lim BT et al (2013) Identifying important comorbidity among cancer populations using administrative data: prevalence and impact on survival. Asia Pac J Clin Oncol. doi:10.1111/ajco.12130

    PubMed  Google Scholar 

  • Schmitz KH, Neuhouser ML, Agurs-Collins T et al (2013) Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst 105(18):1344–1354

    Article  PubMed Central  PubMed  Google Scholar 

  • Schonberg MA, Marcantonio ER, Li D et al (2010) Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol 28(12):2038–2045

    Article  PubMed Central  PubMed  Google Scholar 

  • Schonberg MA, Marcantonio ER, Ngo L et al (2011) Causes of death and relative survival of older women after a breast cancer diagnosis. J Clin Oncol 29(12):1570–1577

    Article  PubMed Central  PubMed  Google Scholar 

  • Shayne M, Crawford J, Dale DC et al (2006) Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy. Breast Cancer Res Treat 100(3):255–262

    Article  PubMed  Google Scholar 

  • Siegelmann-Danieli N, Khandelwal V, Wood GC et al (2006) Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach. Clin Breast Cancer 7(1):59–66

    Article  PubMed  Google Scholar 

  • Sloan FA, Acquah KF, Lee PP et al (2012) Despite ‘welcome to Medicare’ benefit, one in eight enrollees delay first use of part B services for at least two years. Health Aff (Millwood) 31(6):1260–1268

    Google Scholar 

  • Smith AW, Reeve BB, Bellizzi KM et al (2008) Cancer, comorbidities, and health-related quality of life of older adults. Health Care Fin Rev 29(4):41–56

    Google Scholar 

  • Snyder CF, Frick KD, Kantsiper ME et al (2009) Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol 27(7):1054–1061

    Article  PubMed  Google Scholar 

  • Snyder CF, Frick KD, Herbert RJ et al (2013) Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls. J Clin Oncol 31(9):1140–1148

    Article  PubMed Central  PubMed  Google Scholar 

  • Sogaard M, Thomsen RW, Bossen KS et al (2013) The impact of comorbidity on cancer survival: a review. Clin Epidemiol 5(Suppl 1):3–29

    Article  PubMed Central  PubMed  Google Scholar 

  • Stavrou EP, Lu CY, Buckley N et al (2012) The role of comorbidities on the uptake of systemic treatment and 3-year survival in older cancer patients. Ann Oncol 23(9):2422–2428

    Article  CAS  PubMed  Google Scholar 

  • Tammemagi CM, Nerenz D, Neslund-Dudas C et al (2005) Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 294(14):1765–1772

    Article  CAS  PubMed  Google Scholar 

  • US Burden of Disease Collaborators (2013) The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 310(6):591–608

    Article  CAS  Google Scholar 

  • Vaklavas C, Chatzizisis YS, Tsimberidou AM (2011) Common cardiovascular medications in cancer therapeutics. Pharmacol Ther 130(2):177–190

    Article  CAS  PubMed  Google Scholar 

  • Velanovich V, Gabel M, Walker EM et al (2002) Causes for the undertreatment of elderly breast cancer patients: tailoring treatments to individual patients. J Am Coll Surg 194(1):8–13

    Article  PubMed  Google Scholar 

  • Vendramini-Costa DB, Carvalho JE (2012) Molecular link mechanisms between inflammation and cancer. Curr Pharm Des 18(26):3831–3852

    Article  CAS  PubMed  Google Scholar 

  • Vinayak S, Kurian AW (2009) Statins may reduce breast cancer risk, particularly hormone receptor-negative disease. Curr Breast Cancer Rep 1(3):148–156

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Vulto AJ, Lemmens VE, Louwman MW et al (2006) The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002. Cancer 106(12):2734–2742

    Article  PubMed  Google Scholar 

  • Warren JL, Klabunde CN, Schrag D et al (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl):IV-3-18

    Google Scholar 

  • Weaver KE, Foraker RE, Alfano CM et al (2013) Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv 7(2):253–261

    Article  PubMed Central  PubMed  Google Scholar 

  • Wilson GC, Quillin RC 3rd, Hanseman DJ et al (2013) Incidence and predictors of neuropathic pain following breast surgery. Ann Surg Oncol 20(10):3330–3334

    Article  PubMed  Google Scholar 

  • Yancik R, Ganz PA, Varricchio CG et al (2001a) Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. J Clin Oncol 19(4):1147–1151

    CAS  PubMed  Google Scholar 

  • Yancik R, Wesley MN, Ries LA et al (2001b) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285(7):885–892

    Article  CAS  PubMed  Google Scholar 

  • Zavascki AP, Fuchs SC (2007) The need for reappraisal of AIDS score weight of Charlson comorbidity index. J Clin Epidemiol 60(9):867–868

    Article  PubMed  Google Scholar 

  • Zhang P, Li H, Tan X et al (2013) Association of metformin use with cancer incidence and mortality: a meta-analysis. Cancer Epidemiol 37(3):207–218

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY, 14263, USA

    Chi-Chen Hong Ph.D. & Christine B. Ambrosone Ph.D.

  2. Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 1284-600 University Avenue, Toronto, ON, Canada, M5G 1X5

    Pamela J. Goodwin M.D., M.Sc., F.R.C.P.C.

Authors
  1. Chi-Chen Hong Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christine B. Ambrosone Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pamela J. Goodwin M.D., M.Sc., F.R.C.P.C.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chi-Chen Hong Ph.D. .

Editor information

Editors and Affiliations

  1. Distinguished Professor of Health Policy & Management and Medicine, Director, Cancer Prevention & Control Research, UCLA Fielding School of Public Health, David Geffen School of Medicine at UCLA, Jonsson Comprehensive Cancer Center, Los Angeles, California, USA

    Patricia A. Ganz

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Breast Cancer Research Foundation

About this chapter

Cite this chapter

Hong, CC., Ambrosone, C.B., Goodwin, P.J. (2015). Comorbidities and Their Management: Potential Impact on Breast Cancer Outcomes. In: Ganz, P. (eds) Improving Outcomes for Breast Cancer Survivors. Advances in Experimental Medicine and Biology(), vol 862. Springer, Cham. https://doi.org/10.1007/978-3-319-16366-6_11

Download citation

Publish with us

Policies and ethics

Search

Navigation